Eosinophils
Males, Age 20-29
The median eosinophil count for males aged 20-29 in the US population is 0.2 (x1000 cells/µL), with 90% of this group falling between 0.0 and 0.6.
NHANES 2017-March 2020 Pre-Pandemic 2017-2020 · Sample size: 571 participants · Unit: 1000 cells/µL
Percentile Distribution
| Percentile | P5 | P10 | P25 | P50 | P75 | P90 | P95 |
|---|---|---|---|---|---|---|---|
| Value (1000 cells/µL) | 0.00 | 0.10 | 0.10 | 0.20 | 0.30 | 0.40 | 0.60 |
| 95% CI | 0.00 | 0.00 | 0.10 | 0.20 | 0.20 | 0.30 | 0.40 |
| Percentile | Value (1000 cells/µL) | 95% CI |
|---|---|---|
| P5 | 0.00 | 0.00 |
| P10 | 0.10 | 0.00 |
| P25 | 0.10 | 0.10 |
| P50 | 0.20 | 0.20 |
| P75 | 0.30 | 0.20 |
| P90 | 0.40 | 0.30 |
| P95 | 0.60 | 0.40 |
The 95% confidence interval (CI) is the range of values for the population percentile that are consistent with this sample, given how NHANES selected participants. It describes uncertainty in the percentile, not in any one person's result.
When both bounds equal the percentile, many participants share that reported value, and the whole interval falls on it.
Percent of WBC
The share of total white blood cells that are eosinophils, measured directly by NHANES (not derived from the absolute count).
Eosinophils percent · Sample size: 571 participants · Unit: %
| Percentile | P5 | P10 | P25 | P50 | P75 | P90 | P95 |
|---|---|---|---|---|---|---|---|
| Value (%) | 0.6 | 1 | 1.5 | 2.4 | 3.7 | 6.3 | 7.2 |
| 95% CI | 0.1 | 0.6 | 1.4 | 2.1 | 3.2 | 5.1 | 6.6 |
| Percentile | Value (%) | 95% CI |
|---|---|---|
| P5 | 0.6 | 0.1 |
| P10 | 1 | 0.6 |
| P25 | 1.5 | 1.4 |
| P50 | 2.4 | 2.1 |
| P75 | 3.7 | 3.2 |
| P90 | 6.3 | 5.1 |
| P95 | 7.2 | 6.6 |
The 95% confidence interval (CI) is the range of values for the population percentile that are consistent with this sample, given how NHANES selected participants. It describes uncertainty in the percentile, not in any one person's result.
Data and Methodology
- Dataset
- NHANES 2017-March 2020 Pre-Pandemic ( NHANES 2017-2020 2020 , Survey-weighted percentiles from pre-pandemic MEC sample)
- Survey years
- 2017-2020
- Measurement
- Calculated: (Eosinophil percentage / 100) × WBC, in 1000 cells/µL. How it was measured
- Sample size
- 571 participants
- Reference population
- US civilian non-institutionalized males aged 20-29 from NHANES 2017-March 2020. Includes the full population (not restricted to healthy individuals) to reflect the population distribution.
- Exclusion criteria
-
- Missing eosinophils measurement
- Missing or zero MEC sample weight (WTMECPRP)
- Age outside 20-29 range
- Notes
- Percentiles computed using survey-weighted analysis (WTMECPRP weight from the pre-pandemic combined file). Eosinophils measured as LBDEONO in 1000 cells/µL.
Data and Methodology (Percent of WBC)
- Dataset
- NHANES 2017-March 2020 Pre-Pandemic ( NHANES 2017-2020 2020 , Survey-weighted percentiles from pre-pandemic MEC sample)
- Survey years
- 2017-2020
- Measurement
- Percent of WBC: Measured by VCS technology (volume, conductivity and scatter) on Beckman Coulter DxH 800. How it was measured
- Sample size
- 571 participants
- Reference population
- US civilian non-institutionalized males aged 20-29 from NHANES 2017-March 2020. Includes the full population (not restricted to healthy individuals) to reflect the population distribution.
- Exclusion criteria
-
- Missing eosinophils percent-of-WBC measurement
- Missing or zero MEC sample weight (WTMECPRP)
- Age outside 20-29 range
- Notes
- Percent-of-WBC distribution computed using survey-weighted analysis (WTMECPRP weight). Eosinophils percent measured as LBXEOPCT, a distinct NHANES variable from the absolute count.